Purification of Human Factor IX by Chromatography of a Coagulation Factor Concentrate

Hannu Suomela

doi:10.1055/s-0038-1647946

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1976; 35(01): 211-221
DOI: 10.1055/s-0038-1647946

Original Article

Schattauer GmbH

Purification of Human Factor IX by Chromatography of a Coagulation Factor Concentrate

Hannu Suomela

¹Finnish Red Cross Blood Transfusion Service, Kivihaantie 7, 00310 Helsinki 31, Finland

› Author Affiliations

Abstract

Summary

A purification procedure for, and some properties of, coagulation factor IX are described. The coagulation factor concentrate used for the treatment of hemophilia B patients was employed as the starting material. The isolation procedure consists of chromatography in DEAE-cellulose, two chromatographies in hydroxyapatite gel and two gel filtrations in Sephadex G-200. Only trace amounts of factors II, VII and X were present in the final preparation and the specific activity of factor IX was 159 corresponding 10,300 times purification from plasma. The molecular weight was estimated to be 76,000 in gel filtration and 86,000 in sodium dodecyl sulfate disc gel electrophoresis. Three activity peaks with pis 4.15, 4.25 and 4.40 were obtained by isoelectric focusing.

Full Text

References

References
1 Anderson L.-O, Borg H, Miller-Andersson M. 1973. Purification of factor IX by affinity chromatography. In: Proceedings of the Fourth International Congress on Thrombosis and Haemostasis. Vienna: June 19-22nd 1973. Abstract No. 109, p. 142.
2 Bidwell E, Booth J. M, Dike G. W. R, Denson K. W. E. 1967; Preparation for therapeutic use of concentrate of factor IX containing also factors n, VII and X. British Journal of Haematology 13: 568.
3 Biggs R, Douglas A. S, Macearlane R. G, Dacie J. V, Pitney W. R, Merkey C, O’Brien J. R. 1952; Christmas disease: A condition previously mistaken for haemophilia. British Medical Journal 2: 1378.
4 Chandra S, Pechet L. 1973; The separation of clotting factors. II. Purification of human factor IX by isoelectric focusing. Biochemica et Biophysica Acta 328: 456.
5 Denson K. W. E. 1967. The Use of Antibodies in the Study of Blood Coagulation. I. The preparation of purified coagulation factors for use in the production of antisera in rabbits. Blackwell Scientific Publications; Oxford (& Edinburgh): 17.
6 Fujikawa K, Thompson A. R, Legaz M. E, Meyer R. G, Davie E. W. 1973; Isolation and characterization of bovine factor IX (Christmas factor). Biochemistry 12: 4938.
7 Hardisty R. M, Macpherson Janet C. 1962; A one-stage factor VIII (Antihaemophilic globulin) assay and its use on venous and capillary plasma. Thrombosis et Diathesis Haemorrhagica 7: 215.
8 Melin M, Pennel R. B, Tullis J. L, Bandanza P, Di Francesco A, Jansky J. 1965; Studies in the chromatography of trace constituents of human plasma. I. A crude prothrombin- containing fraction. Bibliotheca Haematologica 23: 1228.
9 Østerud B. 1973. Purification and some characteristics of human factor IX. In: Proceedings of the Fourth International Congress on Thrombosis and Haemostasis. Vienna: June 19—22nd 1973. Abstract No. 108, p. 141.
10 Østerud B, Schiffman S. 1972; Gel filtration properties of factors II, VII, IX, IXa and X. Thrombosis et Diathesis Haemorrhagica 28: 317.
11 Pyörälä K. 1965; Determinants of the clotting factor response to warfarin in the rat. Annales Medicinae Experimentalis et Biologiae Fenniae 43 suppl. 3.
12 Pechet L, Smith J. A. 1970; The separation of clotting factors II (prothrombin) and IX (plasma thromboplastin component) by isoelectric focusing. Biochimica et Biophysica Acta 200: 475.
13 Somer J. B, Castaldi P. A. 1970; Coagulation factor X in normal and Haemophilia B plasma. British Journal of Haematology 18: 147.
14 Soulier J. P, Blatrix C, Prou-Wartelle O, Vignal A. 1962; Préparation d’une fraction serique riche en convertine (VII), facteur Stuart (X) et facteur antihémophilique B (IX). Nouvelle Revue Française d’Hématologie 2: 27.
15 Suomela H. 1975; Multiple forms of human factor IX in chromatography and isoelectric focusing. Thrombosis Research 7: 101.
16 Suomela H, Myllylà G. 1971; A factor IX-concentrate for the treatment of Haemophilia B. Duodecim 87: 31.
17 Swart A. C. W, Klaassen B. H. M, Bloys-Van Treslong-De Groot C. H. F, Hemken H. C. 1972; The adsorption of blood coagulation factors II, VII, IX and X from human plasma to aluminium hydroxide. Thrombosis et Diathesis Haemorrhagica 27: 490.
18 Tiselius A, Hjerten S, Levin O. 1956; Protein chromatography on calcium phosphate columns. Archives of Biochemistry and Biophysics 65: 132.
19 Weber K, Osborn M. 1969; The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. Journal of Biological Chemistry 244: 4406.